The user facility reported to terumo cardiovascular that , during vein harvesting procedure, the customer was unable to cauterize.The saphenous vein was eventually harvested via open cut-down approach due to product issue.Product was changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on january 29, 2021.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date) g3 (date received by manufacturer) g6 (indication that this is a follow-up report) h2 (follow-up due to additional information) h6 (identification of evaluation codes 11, 3331, 4114, 3221, 4315) type of investigation code #1: 11 - testing of device from same lot/batch retained by manufactur type of investigation code #2: 3331 - analysis of production records type of investigation code #3: 4114 - device not returned results code: 3221 - no findings available conclusions code: 4315 - cause not established the affected sample was not returned so a thorough investigation could not be conducted.The reported issues were not able to be replicated within the retention sample; therefore, the root cause for this event cannot be determined.During the manufacturing process, the v-cutter mechanism is 100% inspected and tested for functionality and performance prior to packaging.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|